Search

Search

这页已由机器翻译。其他页面可能仍然显示为英文。 View in English

首页
...
研究领域生物医学和临床科学心血管医学和血液学心脏病 (包括心血管疾病)
药理上抑制细胞亡,死细胞亡和铁细胞亡,在老鼠心肌梗塞后提供有效的心脏保护.

药理上抑制细胞亡,死细胞亡和铁细胞亡,在老鼠心肌梗塞后提供有效的心脏保护.

Chanon Piamsiri ^1,2,3, Chayodom Maneechote ^1,3, Kewarin Jinawong ^1,2,3, Busarin Arunsak ^1,3, Titikorn Chunchai ^1,3, Siriporn C Chattipakorn ^1,3,4, Nipon Chattipakorn ^5,6,7,8

Chanon Piamsiri ^1,2,3, Chayodom Maneechote ^1,3, Kewarin Jinawong ^1,2,3

¹Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.
²Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.
³Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, 50200, Thailand.
⁴Department of Oral Biology and Diagnostic Sciences, Faculty of Dentistry, Chiang Mai University, Chiang Mai, 50200, Thailand.
⁵Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand. nchattip@gmail.com.
⁶Cardiac Electrophysiology Unit, Department of Physiology, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand. nchattip@gmail.com.
⁷Center of Excellence in Cardiac Electrophysiology Research, Chiang Mai University, Chiang Mai, 50200, Thailand. nchattip@gmail.com.
⁸The Academy of Science, The Royal Society of Thailand, Bangkok, Thailand. nchattip@gmail.com.

⁰Cardiac Electrophysiology Research and Training Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand.

Scientific Reports +

|

2025年八月24日

相关实验视频

These videos have been matched automatically. Contact us if they are not relevant.

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin <em data-lazy-src=

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

See all related videos

在PubMed上查看摘要

概括

此摘要是机器生成的。

在心肌梗塞 (MI) 后抑制细胞死亡途径,如细胞亡和亡,可以显著改善心脏功能. 这项研究表明,阻断这些细胞死亡类型可以减少小鼠心脏病发作模型中的心脏损伤和功能障碍.

科学领域

心脏病学
分子生物学
病理学

背景情况

心血管疾病,特别是心肌梗塞 (MI),是全球死亡的主要原因.
心脏病后的并发症包括编程细胞死亡 (PCD),加剧心脏功能障碍和心力衰竭.
PCD 抑制剂在心脏病后的治疗潜力尚不清楚.

研究的目的

在小鼠心肌梗塞模型中研究抑制亡和亡的疗效.
评估PCD抑制剂对心脏重塑,功能和心肌损伤后的影响.

主要方法

建立了一种小鼠MI模型,随后使用载体,埃纳拉普利尔,zVAD- FMK (亡抑制剂),Necrostatin- 1 (亡抑制剂) 或Ferrostatin- 1 (亡抑制剂) 治疗32天.
通过心声学和压力-体积循环研究来评估心脏功能.
分析了线粒体功能,细胞病理和细胞死亡和心脏重塑的分子标记.

主要成果

用zVAD-FMK,Necrostatin-1和Ferrostatin-1治疗显著缓解了病态心脏重塑.
这些抑制剂减少了细胞亡和死细胞亡介导的心肌损伤.
线粒体功能障碍得到缓解,整体心脏功能得到改善.

结论

抑制亡和亡是一种有前途的治疗策略,用于治疗心肌梗塞后的疾病.
针对特定的细胞死亡途径可以预防或减少心肌损失,并在缺血事件后改善心脏功能.

关键词:

细胞亡心血管疾病铁症心脏衰竭线粒体心肌梗塞尸体死亡编程细胞死亡

相关实验视频

这些视频已自动匹配 Contact us 如果它们不相关

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin <em>via</em> PINK1/Parkin Pathway-Mediated Mitophagy

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

See all related videos

相关概念视频

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Share

X
Facebook
LinkedIn
YouTube

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

AUTHORS

Publishing Process
Editorial Board
Scope & Policies
Peer Review
FAQ
Submit

LIBRARIANS

Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

RESEARCH

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

EDUCATION

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Terms & Conditions of Use
Privacy Policy
Policies